Centene (NYSE:CNC – Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Friday, February 6th. Analysts expect Centene to post earnings of ($1.25) per share and revenue of $48.4133 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 9:00 AM ET.
Centene (NYSE:CNC – Get Free Report) last released its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.71. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.The business had revenue of $49.69 billion for the quarter, compared to analyst estimates of $47.50 billion. During the same period in the previous year, the company posted $1.62 EPS. The company’s revenue was up 18.2% compared to the same quarter last year. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Centene Stock Up 3.8%
Shares of NYSE CNC opened at $43.50 on Friday. The stock’s 50-day simple moving average is $41.72 and its 200-day simple moving average is $35.39. Centene has a 1 year low of $25.08 and a 1 year high of $66.81. The firm has a market cap of $21.38 billion, a price-to-earnings ratio of -4.02, a PEG ratio of 0.97 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08.
Institutional Trading of Centene
Analysts Set New Price Targets
A number of analysts have commented on the stock. Oppenheimer reaffirmed an “outperform” rating and set a $45.00 price objective on shares of Centene in a research note on Thursday, October 30th. Morgan Stanley increased their price objective on shares of Centene from $28.00 to $38.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 14th. The Goldman Sachs Group reiterated a “sell” rating and issued a $38.00 target price (up from $33.00) on shares of Centene in a report on Thursday, October 30th. Cantor Fitzgerald boosted their price objective on shares of Centene from $38.00 to $41.00 and gave the stock a “neutral” rating in a research report on Thursday, October 30th. Finally, Zacks Research upgraded Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $40.81.
Read Our Latest Stock Analysis on Centene
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- What a Former CIA Agent Knows About the Coming Collapse
- Inside: Pre-IPO Ticker + The Next Elon Musk?
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Buy this Gold Stock Before May 2026
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
